Stay updated on Pembrolizumab for HNSCC Residual Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for HNSCC Residual Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for HNSCC Residual Disease Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, making the study record inaccessible. The prior study documents and related navigation have been removed, leaving only the error message and site footer.
    Difference
    19%
    Check dated 2026-09-19T22:23:40.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.5 to v3.6.6, indicating a minor version update in the page documentation.
    Difference
    0.1%
    Check dated 2026-08-29T18:59:59.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a small internal release update to the page's versioning metadata.
    Difference
    0.1%
    Check dated 2026-08-08T22:27:50.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.6.4, representing a minor page update with no change to study data or eligibility details.
    Difference
    0.1%
    Check dated 2026-07-25T16:53:12.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.6.3, replacing the previous Revision: v3.6.2; this reflects a small software version update tied to the page rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-07-04T03:58:30.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.0 to v3.6.2. This indicates an updated version of the ClinicalTrials.gov record, suggesting minor edits or corrections to the study information.
    Difference
    0.1%
    Check dated 2026-06-27T02:13:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for HNSCC Residual Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for HNSCC Residual Disease Clinical Trial page.